Related Experiment Video

Updated: May 15, 2026

A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies
04:47

A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies

Published on: February 23, 2018

Combination of Fc-Protein Engineering Strategies: Design and Evaluation of Antibody Effector Functions

Carina Lynn Gehlert1, Steffen Krohn1, Dorothee Winterberg1

  • 1Division of Antibody-Based Immunotherapy, Department of Internal Medicine II, Kiel University and University Hospital Schleswig-Holstein, Campus Kiel, Germany.

Methods in Molecular Biology (Clifton, N.J.)
|May 13, 2026
PubMed

Insights

Monoclonal antibody therapy can be improved by engineering the Fc region to enhance effector functions. This optimization aims to increase the efficacy of antibody-based cancer treatments for more patients.

Area of Science:

  • Immunology
  • Oncology
  • Biotechnology

Background:

  • Monoclonal antibodies are vital in cancer therapy but do not benefit all patients.
  • Fc-mediated effector functions are crucial for antibody therapy efficacy.
  • Current therapies have limitations in patient response rates.

Purpose of the Study:

  • To explore antibody Fc engineering for optimizing cancer immunotherapy.
  • To enhance Fc-mediated effector functions for improved therapeutic outcomes.
  • To develop next-generation monoclonal antibodies with tailored functions.

Main Methods:

  • Review of preclinical and clinical findings on Fc-mediated effector functions.
  • Analysis of antibody Fc engineering strategies.
  • Evaluation of effector functions like ADCC, ADCP, and CDC.

Main Results:

  • Fc-mediated effector functions significantly impact antibody therapy success.
  • Fc engineering offers a pathway to enhance these functions.
  • Optimized effector functions show potential for increased therapeutic efficiency.

Conclusions:

  • Antibody Fc engineering is a promising strategy for next-generation cancer immunotherapies.
  • Enhancing antibody-dependent cell-mediated cytotoxicity (ADCC), antibody-dependent cellular phagocytosis (ADCP), and complement-dependent cytotoxicity (CDC) can improve treatment outcomes.
  • Tailor-made effector functions are key to maximizing the clinical benefit of monoclonal antibodies.
Keywords:
ADCCADCPAntibody therapyCDCFc engineering

More Related Videos

Protein Engineering by Yeast Surface Display05:49

Protein Engineering by Yeast Surface Display

Published on: November 29, 2024

Bacterial Inner-membrane Display for Screening a Library of Antibody Fragments12:28

Bacterial Inner-membrane Display for Screening a Library of Antibody Fragments

Published on: October 15, 2016

Related Concept Videos

Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
Antibody Structure01:10

Antibody Structure

Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibody Structure01:10

Antibody Structure

Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibody Structure and Classes01:25

Antibody Structure and Classes

Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
Antibody Actions01:26

Antibody Actions

Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Diversity of Antigen Receptors01:28

Diversity of Antigen Receptors

Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...